Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: May 7, 2026
Date Accepted: Jul 31, 2026
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
When Innovation Leaves People Behind: Reframing Accountability in Commercial Digital Health
ABSTRACT
Digital technologies are increasingly integrated across healthcare systems, yet accumulating evidence shows that these tools often perform unevenly across population groups. Biases in artificial intelligence‑enabled tools can reinforce existing health inequities, particularly when systems are developed and validated using datasets that exclude underserved populations. Studies demonstrate systematic underestimation of illness severity, diagnostic inaccuracies, and measurement bias affecting ethnic minority groups, rural populations, people with disabilities, homeless individuals, and other groups with limited access to healthcare. These disparities highlight structural vulnerabilities in the data that inform machine learning systems, where socially patterned access to care shapes what is recorded and therefore learned. Commercial adoption patterns further exacerbate inequities due to socioeconomic gradients in digital engagement. Ensuring accountability in digital health requires transparent reporting of subgroup performance, representative development of datasets, and ongoing monitoring of distributional impacts. Achieving equitable and reliable digital healthcare demands regulatory and methodological standards that prioritise fairness and generalisability.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.